Common Equity: The sum of all common equity items.
Ascentage Pharma Group International - Unsponsored ADR (AAPG) had Common Equity of $190.79M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$82.10M |
|
$-177.71M |
|
$7.00M |
|
$75.10M |
|
$251.16M |
|
$-169.07M |
|
$-7.69M |
|
$-176.75M |
|
$-176.75M |
|
$-177.75M |
|
$-177.75M |
|
$-177.75M |
|
$-177.75M |
|
$-169.07M |
|
$-169.07M |
|
88.86M |
|
88.86M |
|
$-2.00 |
|
$-2.00 |
|
| Balance Sheet Financials | |
$421.01M |
|
$111.72M |
|
$145.77M |
|
$566.78M |
|
$235.00M |
|
$108.28M |
|
$141.00M |
|
$375.99M |
|
|
Common Equity |
$190.79M |
$177.83M |
|
$190.79M |
|
93.33M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|